Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation

Status:
RECRUITING

Trial end date:
2026-11-30

Target enrollment:

Participant gender:

This pilot study will evaluate the feasibility of at least twice daily use of azelaic acid in breast cancer patients undergoing radiation treatment.

PHASE1

Virginia Commonwealth University

azelaic acid